新Sci-Hub来了,2亿免费全文文献!Semantic Scholar 详细介绍

2021-12-13 网络 网络

你还在用pubmed、谷歌学术去搜索文献吗?今天给大家带来一个数百万学者都在使用的AI 学术搜索引擎---Semantic Scholar!关键还能免费下载PDF文件!完全可以取代Sci-Hub! 话

你还在用pubmed、谷歌学术去搜索文献吗?你是不是使用Sci-hub,经常网址被封?

今天给大家带来一个数百万学者都在使用的AI 学术搜索引擎---Semantic Scholar!关键还能免费下载PDF文件!完全可以取代Sci-Hub! 话不多说,直接来网址,国内访问速度很快!大家记得多关注梅斯医学哦,经常有干货给您!

官网网址:https://www.semanticscholar.org

1、Semantic Scholar 介绍

Semantic Scholar 于 2015 年启动,是 Allen Institute for AI 的一个开创性项目,Allen Institute for AI 是一家成立于 2014 年的非营利性研究机构,其使命是进行高影响力的 AI 研究和工程,为公共利益服务。AI2 是微软联合创始人 Paul Allen 的创造,由领先的 AI 研究员 Oren Etzioni 博士领导。

它是基于人工智能自主学习的学术搜索引擎,可以快速筛选出相关有用内容,且能在一定程度上理解这些内容。同时还能展示相关主题历年文章发表量趋势,相关主题推荐内容等,关键是它能直接提供全文下载,而且免费。

图片

 

经过几年的发展,Semantic Scholar收集的文献数量已经突破2亿篇,内容丰富。

学科范围:Semantic Scholar 几乎覆盖所有的学科领域。

文献类型:学术期刊、学术会议及学术机构的学术文献。

文献语种:目前主要是英语文献,将来可能支持其他语言。

合作伙伴:全球500多家学术出版商、大学出版社和学术团体

图片

Semantic Scholar 利用人工智能机器学习技术,从文献文本中挑选出最重要的关键词或短语,确定文献的研究主题,也可以从文献中提取图片和图表,呈现在文献检索页面,能够帮助使用者快速理解文献的主要内容。

对于科学研究人员来说,Semantic Scholar 的最大用处就是可以帮助研究人员快速获得重要文献,因为该引擎可以辨别一篇文章引用的参考文献是否具有重要的参考价值.

2、Semantic Scholar 使用技巧

网站使用非常简单,只需输入关键词搜索即可得到目标文献。默认按相关性排序,还可选择按被引次数、最具影响力论文、时间排序。而且大多提供了全文可免费下载。

官网网址:https://www.semanticscholar.org

图片

首先打开官网,下面以关键词“基因编辑”为例搜索,可以得到 635万 篇文献。

图片

可以选择多个项目进行排序或筛选。

图片

pdf图标上有一把打开的锁表示这些文献是“open access”类型的PDF。点击可直接下载pdf,或跳转到另一个可以下载pdf的网站上。

图片

其他包含pdf图标的是可以提供pdf直链下载地址的,点击PDF图标可直接下载文献。

图片

下图是获取的一篇文献。如果你希望保存到本地硬盘中,只需要点击右上方的下载图标即可。

图片

3、检索技巧

因为检索结果太多,因此,如果不认真检索,可能检索不出你想要的内容哦。

建议:

(1)首先按时间筛选,选择最近3年或当年的文献。以保证文献的新颖度。

(2)限定领域(field),有助于缩小检索范围,排除无关文献。

(3)多个关键词,或增加关键词的数量

好东西,不用过多描述,相信大家看到就如获至宝,赶紧收藏下来吧。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-11-10 gjsgj
  2. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-15 fengyi812
  3. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-14 查查佳佳

    疗是许多肿瘤治疗的重要手段,化疗相关毒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-14 zy&kt

    收藏,谢了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-13 ms1000000203803067

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1793684, encodeId=7bbd1e936844b, content=<a href='/topic/show?id=df0a1598991' target=_blank style='color:#2F92EE;'>#Scholar#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15989, encryptionId=df0a1598991, topicName=Scholar)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Thu Nov 10 03:07:26 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317677, encodeId=d192131e6777f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Dec 15 13:07:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079835, encodeId=00f410e9835ca, content=疗是许多肿瘤治疗的重要手段,化疗相关毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Tue Dec 14 09:16:35 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079766, encodeId=6bbf10e976618, content=收藏,谢了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46905128057, createdName=zy&kt, createdTime=Tue Dec 14 00:36:12 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079745, encodeId=a1fb10e974598, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfce6397944, createdName=ms1000000203803067, createdTime=Mon Dec 13 23:07:26 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079715, encodeId=a10110e9715aa, content=干货,收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Dec 13 22:11:18 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-13 mswert122

    干货,收藏了

    0

相关资讯

Sci-Hub被判应向科学出版商爱思唯尔赔偿千万美元

6月21日,全球最大的科学出版商之一爱思唯尔赢得了对Sci-Hub等盗版网站的缺席判决,这些网站提供了数千万科研论文和书籍的非法下载。纽约一家地区法院判决Sci-Hub、LibGen和其它相关网站向爱思唯尔支付1500万美元,作为侵犯其版权的赔偿金。

Sci-Hub或永久封停,战斗民族终于下手

目前Sci-Hub所有备用域名均不可用了!@nezzzii发表动态称:pleaseeee!!!!! not these days. I need to finish my thesisBrandy - Haven't You Heard近日,莫斯科市法院命令俄罗斯联邦通信、信息技术和大众传媒监督局(Roskomnadzor)封锁Sci-Hub网站,起因或为某知名出版商起诉。这意味着,俄罗斯境内今后

收藏:媲美Sci-hub神器来了,论文书籍一网打尽

华东师范大学的朱国华教授曾说,“俄罗斯人开的网站http://gen.lib.rus.ec/为全世界读书人带来了功德无量的便利,我的绝大部分英文书是从该网站中下载得到,但愿此网站万世不倒。" Library Genesis号称是帮助全人类知识无版权传播的计划。网站上论文很多,下载方便,还有很多外文书籍和中文书籍,几乎每天都在更新。这也是一个拥有80多万本图书让你随意下载的网站,99%是科学著作且

喜大普奔!Sci-hub可能正常使用了(附全新可用链接)

日前,学术出版商EIsevier与Sci-hub达成和解,承认其合法地位。这意味着EIsevier旗下的期刊将能够被允许在Sci-hub上检索并进行全文下载。 据悉,这一决定是EIsevier迫于多方压力做出的让步。此前,多所大学及研究机构发起抵制EIsevier的活动,理由是其收取极高的订阅费用。 抵制EIsevier的活动的发起人Norman Minerva教授称,这是一次小的

收藏帖:再不用担心Sci-Hub不能用了

提到Sci-Hub这个文献下载利器,大家肯定都不陌生。你在各大SCI杂志上看到的英文文献,90%以上都能免费下载。因为它严重侵犯了爱思唯尔、施普林格、Wiley等各大出版商的利益,遭到起诉与封杀。 不断有新的网址,不断被封杀,这个问题如何解决呢?这里介绍几招,永久解决这个问题:一、使用新的网址目前可以访问的SCI-HUB最新网址:1. http://sci-hub.tw/(最新)2. http: